scholarly article | Q13442814 |
P50 | author | Lisa M DeAngelis | Q53760126 |
Maria Kryza-Lacombe | Q87028784 | ||
P2093 | author name string | Kathryn Beal | |
Denise D Correa | |||
Raymond E Baser | |||
P2860 | cites work | The APOE genotype: modification of therapeutic responses in Alzheimer's disease | Q38261442 |
Do cholinesterase inhibitors act primarily on attention deficit? A naturalistic study in Alzheimer's disease patients | Q38435326 | ||
A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor | Q39701844 | ||
Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer | Q40306862 | ||
Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease | Q43545906 | ||
Cognitive dysfunction in people with cancer | Q43730922 | ||
The effects of continuous and single-dose radiation on choline uptake in organotypic tissue slice cultures of rabbit hippocampus | Q43731141 | ||
A pilot study of donepezil for memory problems in epilepsy | Q44332061 | ||
The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study | Q44506646 | ||
Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial | Q44582685 | ||
Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease | Q46653039 | ||
Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life | Q48611317 | ||
Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. | Q50998019 | ||
Cognitive functions in survivors of primary central nervous system lymphoma. | Q52002457 | ||
The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. | Q52880557 | ||
Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. | Q54299544 | ||
Effects of X-irradiation on nerve growth factor in the developing mouse brain | Q73039686 | ||
Subjective Memory Complaints and Cognitive Impairment in Older People | Q22306419 | ||
Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy | Q33385596 | ||
APOE polymorphisms and cognitive functions in patients with brain tumors | Q33972402 | ||
A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients | Q34516967 | ||
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study | Q35467921 | ||
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. | Q35486482 | ||
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis | Q35566553 | ||
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial. | Q35598799 | ||
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target | Q35776955 | ||
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. | Q36023980 | ||
Mechanisms of radiation-induced brain toxicity and implications for future clinical trials | Q37062099 | ||
The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial | Q37187724 | ||
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial | Q37187732 | ||
Neural precursor cells and central nervous system radiation sensitivity | Q37195860 | ||
Subjective perception of cognition is related to mood and not performance | Q37208054 | ||
Radiation-induced brain injury: A review | Q38029608 | ||
Effect of cholinesterase inhibitors on attention | Q38050593 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | brain tumor | Q233309 |
P304 | page(s) | 313-319 | |
P577 | publication date | 2016-01-06 | |
P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
P1476 | title | Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study | |
P478 | volume | 127 |
Q46352209 | A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas. |
Q89794198 | Chemotherapy-Related Cognitive Impairment #342 |
Q50533188 | Cognitive Impairment Associated with Cancer: A Brief Review. |
Q49971341 | Cognitive deficits following brain tumor radiation therapy |
Q92308274 | Impact of androgen deprivation therapy on mood, cognition, and risk for AD |
Q91360370 | Pharmacologic management of cognitive impairment induced by cancer therapy |
Q38891759 | Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients |
Q88705481 | Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105 |
Q39458668 | Sigma1 Pharmacology in the Context of Cancer |
Q89113577 | Symptom-based interventions to promote quality survivorship |
Q93096552 | Treatment of cognitive deficits in brain tumour patients: current status and future directions |
Search more.